Rankings
▼
Calendar
LSTA FY 2010 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
LSTA
Lisata Therapeutics, Inc.
$44M
FY 2010 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$70M
+503.7% YoY
Gross Profit
$20M
28.9% margin
Operating Income
-$19M
-27.0% margin
Net Income
-$23M
-33.4% margin
EPS (Diluted)
$-677.08
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$25M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$143M
Total Liabilities
$57M
Stockholders' Equity
$49M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$70M
$12M
+503.7%
Gross Profit
$20M
$4M
+406.6%
Operating Income
-$19M
-$26M
+27.0%
Net Income
-$23M
-$26M
+10.9%
← FY 2009
All Quarters
FY 2011 →